228 related articles for article (PubMed ID: 27501284)
1. Histamine elimination from the cerebrospinal fluid across the blood-cerebrospinal fluid barrier: involvement of plasma membrane monoamine transporter (PMAT/SLC29A4).
Usui T; Nakazawa A; Okura T; Deguchi Y; Akanuma SI; Kubo Y; Hosoya KI
J Neurochem; 2016 Nov; 139(3):408-418. PubMed ID: 27501284
[TBL] [Abstract][Full Text] [Related]
2. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Carrier-Mediated Transport at the Blood-Cerebrospinal Fluid Barrier in Spermine Clearance from Rat Brain.
Akanuma SI; Shimada H; Kubo Y; Hosoya KI
Biol Pharm Bull; 2017; 40(9):1599-1603. PubMed ID: 28867747
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers.
Okura T; Kato S; Takano Y; Sato T; Yamashita A; Morimoto R; Ohtsuki S; Terasaki T; Deguchi Y
J Pharm Sci; 2011 Sep; 100(9):3924-38. PubMed ID: 21538354
[TBL] [Abstract][Full Text] [Related]
5. Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene.
Duan H; Wang J
J Biol Chem; 2013 Feb; 288(5):3535-44. PubMed ID: 23255610
[TBL] [Abstract][Full Text] [Related]
6. The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process.
Tachikawa M; Kasai Y; Takahashi M; Fujinawa J; Kitaichi K; Terasaki T; Hosoya K
J Neurochem; 2008 Oct; 107(2):432-42. PubMed ID: 18752646
[TBL] [Abstract][Full Text] [Related]
7. A clearance system for prostaglandin D2, a sleep-promoting factor, in cerebrospinal fluid: role of the blood-cerebrospinal barrier transporters.
Tachikawa M; Tsuji K; Yokoyama R; Higuchi T; Ozeki G; Yashiki A; Akanuma S; Hayashi K; Nishiura A; Hosoya K
J Pharmacol Exp Ther; 2012 Dec; 343(3):608-16. PubMed ID: 22931759
[TBL] [Abstract][Full Text] [Related]
8. Transporter-mediated L-glutamate elimination from cerebrospinal fluid: possible involvement of excitatory amino acid transporters expressed in ependymal cells and choroid plexus epithelial cells.
Akanuma S; Sakurai T; Tachikawa M; Kubo Y; Hosoya K
Fluids Barriers CNS; 2015 Apr; 12():11. PubMed ID: 25925580
[TBL] [Abstract][Full Text] [Related]
9. Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant.
Tachikawa M; Fujinawa J; Takahashi M; Kasai Y; Fukaya M; Sakai K; Yamazaki M; Tomi M; Watanabe M; Sakimura K; Terasaki T; Hosoya K
J Neurochem; 2008 Nov; 107(3):768-78. PubMed ID: 18761709
[TBL] [Abstract][Full Text] [Related]
10. In-vivo and in-vitro evidence of a carrier-mediated efflux transport system for oestrone-3-sulphate across the blood-cerebrospinal fluid barrier.
Kitazawa T; Hosoya K; Takahashi T; Sugiyama Y; Terasaki T
J Pharm Pharmacol; 2000 Mar; 52(3):281-8. PubMed ID: 10757415
[TBL] [Abstract][Full Text] [Related]
11. Live Tissue Imaging Reveals Distinct Transcellular Pathways for Organic Cations and Anions at the Blood-Cerebrospinal Fluid Barrier.
Hu T; Zha W; Sun A; Wang J
Mol Pharmacol; 2022 May; 101(5):334-342. PubMed ID: 35193935
[TBL] [Abstract][Full Text] [Related]
12. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
Zhang Z; Tachikawa M; Uchida Y; Terasaki T
Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
[TBL] [Abstract][Full Text] [Related]
13. A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat.
Hosoya K; Hori S; Ohtsuki S; Terasaki T
Adv Drug Deliv Rev; 2004 Oct; 56(12):1875-85. PubMed ID: 15381338
[TBL] [Abstract][Full Text] [Related]
14. Role of the blood-cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E₂ produced in the brain.
Tachikawa M; Ozeki G; Higuchi T; Akanuma S; Tsuji K; Hosoya K
J Neurochem; 2012 Dec; 123(5):750-60. PubMed ID: 22978524
[TBL] [Abstract][Full Text] [Related]
15. Transport systems of serine at the brain barriers and in brain parenchymal cells.
Kasai Y; Tachikawa M; Hirose S; Akanuma S; Hosoya K
J Neurochem; 2011 Jul; 118(2):304-13. PubMed ID: 21592122
[TBL] [Abstract][Full Text] [Related]
16. Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins.
Wu KC; Lu YH; Peng YH; Hsu LC; Lin CJ
J Neurochem; 2015 Dec; 135(6):1178-88. PubMed ID: 26376205
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of quinolone antibiotics in rats: efflux from cerebrospinal fluid to the circulation.
Ooie T; Suzuki H; Terasaki T; Sugiyama Y
Pharm Res; 1996 Jul; 13(7):1065-8. PubMed ID: 8842046
[TBL] [Abstract][Full Text] [Related]
18. Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes.
Uchida Y; Goto R; Takeuchi H; Łuczak M; Usui T; Tachikawa M; Terasaki T
Drug Metab Dispos; 2020 Feb; 48(2):135-145. PubMed ID: 31771948
[TBL] [Abstract][Full Text] [Related]
19. In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate.
Ohtsuki S; Takizawa T; Takanaga H; Terasaki N; Kitazawa T; Sasaki M; Abe T; Hosoya K; Terasaki T
Mol Pharmacol; 2003 Mar; 63(3):532-7. PubMed ID: 12606759
[TBL] [Abstract][Full Text] [Related]
20. Processing mechanism of guanidinoacetate in choroid plexus epithelial cells: conversion of guanidinoacetate to creatine via guanidinoacetate N-methyltransferase and monocarboxylate transporter 12-mediated creatine release into the CSF.
Jomura R; Akanuma SI; Kubo Y; Tachikawa M; Hosoya KI
Fluids Barriers CNS; 2022 Jun; 19(1):42. PubMed ID: 35658878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
